Outcome of catheter ablation for paroxysmal atrial fibrillation in patients with stable coronary artery disease

• Published in: Pacing and clinical electrophysiology Vol. 45; no. 9; pp. 1032 - 1041
• Main Authors: Cui, Yi‐Kai, Dong, Jian‐Zeng, Du, Xin, Hu, Rong, He, Liu, Long, De‐Yong, Bai, Rong, Yu, Rong‐Hui, Sang, Cai‐Hua, Jiang, Chen‐Xi, Liu, Nian, Li, Song‐Nan, Wang, Wei, Guo, Xue‐Yuan, Zhao, Xin, Zuo, Song, Tang, Ri‐Bo, Ma, Chang‐Sheng
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc 01.09.2022
• Subjects: Ablation; atrial fibrillation; atrial fibrillation recurrence; Cardiac arrhythmia; Cardiovascular disease; catheter ablation; Catheters; Chronic obstructive pulmonary disease; Coronary artery; coronary artery disease; Coronary vessels; Fibrillation; Heart diseases; Multivariate analysis; Radiofrequency ablation; Statins; Thromboembolism; Vein & artery diseases
• ISSN: 0147-8389; 1540-8159; 1540-8159
• DOI: 10.1111/pace.14571

Background Atrial fibrillation (AF) and stable coronary artery disease (SCAD) frequently coexist. This study aimed to assess the long‐term outcome of catheter ablation in patients with paroxysmal AF and SCAD. Methods In total, 12,104 patients with paroxysmal AF underwent catheter ablation in the Chinese Atrial Fibrillation Registry between 2011 and 2019 were screened. A total of 441 patients with SCAD were matched with patients without SCAD in a 1:4 ratio. The primary endpoint was AF recurrence after single ablation. The composite secondary endpoints were thromboembolism, coronary events, major bleeding, all‐cause death. Results Over a mean follow‐up of 46.0 ± 18.9 months, the recurrence rate in patients with SCAD was significantly higher after a single ablation (49.0% vs. 41.9%, p = .03). The very late recurrence rate of AF in the SCAD group was also significantly higher than that in the control group (38.9% vs. 31.2%;p = .04). In multivariate analysis, adjusted with the female, smoking, duration of AF, previous thromboembolism, COPD, and statins, SCAD was independently associated with AF recurrence (adjusted HR, 1.19 [1.02–1.40], p = .03). The composite secondary endpoints were significantly higher in the SCAD group (12.70% vs. 8.54%, p = .02), mainly due to thromboembolism events (8.16% vs. 4.41%, p < .01). Conclusions SCAD significantly increased the risk of recurrence after catheter ablation of paroxysmal AF. The incidence of thromboembolic events after catheter ablation of paroxysmal AF in the patients with SCAD was significantly higher than that in those without SCAD.